Review article and clinical trials

http://www.asco.org/ASCOv2/Home/Education%20&%20Training/Educational%20Book/PDF%20Files/2012/zds00112000028.PDF

It mentions also BKM120 and other new drugs

http://www.dovepress.com/new-and-emerging-treatments-for-estrogen-receptor-positive-breast-canc-peer-reviewed-article-TCRM

Pancreatic cancer gets a new agent

half as few death for one of the most aggressive cancers.   Yeah!
http://www.medscape.com/viewarticle/778018

Presentation on Korean/Asian BC incidences

This presentation includes BC incidence, age distribution and other information on Korea, Japan, China, Israel, Pakistan,India, Philipines and other Asian countries.

What most jump out to me is how the Korean/Japanese/Chinese have a lower incidence but younger demographics of BC.   How Philipines and Pakistan and Israel have the higher rates of BC.    Interesting for people who want to learn from other cultures about what to do what not to do.

http://www.pitt.edu/~super4/41011-42001/41081.pdf

PD-991 may qualify for the Fast track

Pfizer wants to fast track this miracle drug based on strong phase II results:
http://www.pfizer.com/files/news/asco/pd_0332991_cdk_4_6_inhibitor_fact_sheet.pdf
http://www.bloomberg.com/news/2013-01-10/pfizer-may-push-5-billion-breast-cancer-hope-for-ruling.html

There are more drugs in the pipeline that is based on the same principle from other drug makers

http://www.kantarhealth.com/blog/oncology/stephanie-hawthorne/2012/12/06/CDK_Inhibition_The_Next_Big_Thing_in_ER_Breast_Cancer_Impresses_at_SABCS_2012

Last December news about PD-991:  26 month PFS (PD-991) compared with <10 months PFS with Femara alone
http://killerboob.blogspot.com/2012/12/pd-991-with-femara.html

Foundation Medicine Got More from Bill Gates

Not full-genome sequencing.  but much better than Oncotype or Mammotype.   Costs similar around $5k.

Complete Genomics is another pioneer complete sequencer

http://www.boston.com/businessupdates/2013/01/08/bill-gates-invests-foundation-medicine-which-uses-genome-data-for-cancer-diagnostics/BtipX6STIA5prjmrjJkHzI/story.html

A new angle of attack from Japan via T-cell

T-cell attack from Japan